Skip to main content

Aphria’s marijuana plants intended for medical use grow in their greenhouse in Leamington, Ont., in 2014.

GEOFF ROBINS/The Globe and Mail

Pot stocks received another shot in the arm on Monday after alcohol giant Constellation Brands announced it was buying a near 10-per-cent stake in Canadian marijuana company Canopy Growth Corp. for $245-million.

The agreement is considered a signal of how some alcohol companies plan to respond to the growing acceptance of marijuana for medical and recreational use, given changing legislation, and the potential opportunity for investors in the cannabis sector.

"We see this transaction as a gamechanger for Canopy, as well as the industry at large, " Beacon Securities analyst Vahan Ajamian said in a note on Monday. He has a "buy" rating on Canopy shares and raised his target price to $16 from $14.

Story continues below advertisement

Shares of Canopy Growth Corp., Canada's largest marijuana producer, were up about 15 per cent in mid-morning trading. Other large producers also saw increases including Aphria Inc. and Aurora Cannabis Inc., which saw their shares rise 7 per cent and 4 per cent, respectively. The Horizons Marijuana Life Sciences Index ETF, Canada's first cannabis ETF, was up 6 per cent.

Mr. Ajamian says there has been speculation that alcohol companies would look to enter the sector but that "such a tie-up occurred much sooner than we expected.

"In our view, this highlights the disruption that the alcohol companies are likely to face as recreational cannabis continues its global march forward – and how the leaders in the sector are looking to get in front of it," he said. "We suspect more alcohol companies may look to accelerate plans to enter the industry – as well as pharmaceutical and tobacco companies."

Constellation, a U.S.-based booze distributor behind brands such as Corona beer and Inniskillin wine, said the investment is part of its "long-term strategy to identify, meet and stay ahead of evolving consumer trends and market dynamics," but its focus will remain on its alcohol business.

The "strategic relationship" will see Constellation provide marketing and brand development to Canopy Growth. The companies also said they'll collaborate to develop and market cannabis-based beverages for adults in markets where it's legal.

"Canopy Growth has a seasoned leadership team that understands the legal, regulatory and economic landscape for an emerging market that is predicted to become a significant consumer category in the future," said Constellation Brands CEO Rob Sands in a release. "Our company's success is the result of our focus on identifying early-stage consumer trends, and this is another step in that direction."

Canopy CEO Bruce Linton described Constellation as a "strategic ally" amid the growth of the global cannabis sector."

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter